“…Motivated by the tremendous advances in the field of deep learning [22] and the great potential it has shown in a wide range of clinical decision support applications [23,24,25,26,27,19,28,29], a number of recent studies have explored the efficacy of deep neural networks for the purpose of skin cancer detection [19,28,30,31,32,33,34,35,36,37]. In a recent study by Budhiman et al [19,21], a comprehensive exploration of different residual network architectures was conducted for the purpose of melanoma detection, with the best quantitative results found when leveraging a ResNet-50 [38] architecture.…”